Eli Lilly Loses Appeal of $193 Million Award in Fraud Suit (1)

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.

The US Court of Appeals for the Seventh Circuit rejected several challenges to the 2023 award, including the company’s argument that it had an objectively reasonable interpretation of drug price calculation requirements.

Eli Lilly’s drug price calculations were false, Judge Joshua P.Kolar said, and a jury reasonably found that the company hid the truth from the US government, which deprived the federal health-care program of funds.

Whistleblower Ronald J. Streck filed the suit in ...